ArticleEMBO molecular medicine2022

Anti-tumoural activity of the G-quadruplex ligand pyridostatin against BRCA1/2-deficient tumours.

Florian J Groelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.